Who makes Nobel implants, and where
A Swiss headquarters, a Swedish legal manufacturer, an American parent — and production in three countries
The short answer, because it is usually got wrong
Nobel implants are not made in Switzerland.
The headquarters is Swiss — Kloten, near Zurich. But manufacturing happens elsewhere, and clinics that advertise “Swiss-made implants” are describing an office rather than a factory.
The accurate version: Nobel Biocare is headquartered in Switzerland, its legal manufacturer on most regulatory filings is Swedish, its parent company is American, and production is carried out across facilities in the United States, Sweden and Japan — and historically also Germany. Where a particular implant was made depends on the product.
The three entities
You will meet three names, and they do different jobs.
Nobel Biocare Services AG — Kloten, Switzerland. The group headquarters and the commercial and service structure. This is the entity most commercial agreements and trademark notices name.
Nobel Biocare AB — Gothenburg, Sweden. The regulatory and manufacturing entity, and the one listed as legal manufacturer on FDA submissions, ISO certificates and product documentation. When a regulator needs to know who is responsible for the device, this is the answer.
Envista Holdings Corporation — the parent. A publicly listed dental technology group based in the United States, which also owns Implant Direct, Alpha-Bio Tec, Ormco, DEXIS and Kerr.
That last one surprises people, and it is worth knowing for one specific reason: Implant Direct and Alpha-Bio Tec are value-tier implant brands in the same corporate group as Nobel Biocare. A patient told that premium and budget implants come from entirely separate worlds is being told something simpler than the truth.
Where the manufacturing actually happens
Here the manufacturer’s own statements have shifted, and the honest thing is to show both.
The current company account describes manufacturing across four facilities in the United States, Sweden and Japan. An Envista announcement from December 2021, accompanying the N1 FDA clearance, described five facilities in the United States, Sweden and Germany.
Those are not contradictory so much as different snapshots: manufacturing footprints change, and different product categories may be counted differently. What they establish together is that production is distributed across several countries and is not Swiss.
How to find out where yours came from
Not from a website — including this one. The answer travels with the product:
- The outer box and the sterile blister label
- The UDI-DI — unique device identifier
- The REF / article number
- The LOT / batch number
- The legal manufacturer stated on the packaging
- The Declaration of Conformity
- The product’s instructions for use
- Your local distributor’s traceability record
This is one more argument for keeping your implant record: it is the only route from “a Nobel implant” to “this specific device, from this batch, made by this entity.”
The NobelPearl exception
Worth stating separately because it genuinely differs: NobelPearl is distributed by Nobel Biocare and manufactured by Dentalpoint AG.
It carries the brand and the distribution, and it does not share the manufacturing model of the titanium range. Not a criticism — Dentalpoint is a ceramic implant specialist — but a fact a patient asking who made the object in their jaw is entitled to.
What the quality certification means
Nobel Biocare states that its products and NobelProcera restorations are developed and manufactured under an ISO 13485 compliant quality management system, audited by BSI and subject to inspection by authorities including the FDA. Its published certificates cover ISO 13485, ISO 14001, EU MDR quality system approval, MDSAP and UKCA full quality assurance.
Here is what that establishes, and it is worth being precise:
It does establish that design and manufacturing follow a documented, audited quality system; that products are made to defined procedures; and that traceability and complaint-handling processes exist and are inspected.
It does not establish that any individual implant will not fail, that a system suits a given patient, or that it outperforms a competitor’s.
ISO 13485 is a floor that serious manufacturers stand on, not a ranking. Every established implant manufacturer holds it. A clinic presenting certification as evidence of superiority is presenting a baseline as a distinction.
Why any of this matters to a patient
Three practical reasons, and they are not about national pride.
Regulatory accountability. Knowing the legal manufacturer tells you who is answerable to a regulator if something goes wrong — and who a recall notice comes from.
Component supply. A manufacturer with distributed production and worldwide distribution is more likely to be able to supply the part you need in fifteen years.
Honest expectations. “Swiss-made” is used as a quality signal in dental marketing precisely because it sounds like one. If a clinic tells you that about a Nobel implant, they have either not checked or are relying on you not to — and that is worth knowing about them, separately from anything to do with the implant.
The reasonable conclusion
Where an implant is manufactured matters far less than most marketing implies. Regulatory clearance, a documented quality system, published clinical evidence and long-term component availability are the things that actually protect you, and Nobel Biocare has all four.
What is worth insisting on is that whoever describes it to you gets it right. A clinic that tells you the truth about something as minor as a factory location is more likely to tell you the truth about the things that matter.